Stock information

Idogen is listed on Spotlight Stock Market. See stock information here:
Spotlight Stock Market

Insider tradings

Notification of insider trading exceeding 5000 Euro per year in Idogen should be made to Finansinspektionen and to Idogen at insynsanmalan at idogen dot com.
See Finansinspektionen’s insider registry here:

Finansinspektionens insynsregister

Idogen develops tolerogenic cell therapy – Individualised treatment for each patient

Idogen AB   |   Medicon Village   |   Scheelevägen 2   |   SE-223 81 Lund   |  Sweden   |  E-mail: info at idogen dot com

This project has received funding from the European Union’s Horizon 2020 research and innovation programme.